Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Lithium treatment can cause increased hair shedding and hair loss in patients.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Minoxidil reduces lysine hydroxylase in skin cells.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Using neurohormones to control keratin can lead to new skin disease treatments.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Some plants with flavonoids may help treat hair loss and promote hair growth.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Finasteride helps hair regrowth in frontal fibrosing alopecia.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Apremilast did not work for treating severe alopecia areata.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Green-synthesized nanoparticles can effectively target cancer cells, reducing side effects and improving treatment.

Latanoprost may cause scalp inflammation and delayed healing.

Hair and serum levels of zinc, copper, and iron are similar in people with alopecia areata and healthy individuals.

The exact cause of growth hormone-responsive alopecia in dogs is unclear.

The report described a unique case of Cronkhite-Canada syndrome with unusual polyps and an association with multiple myeloma.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Women with AGA have less hair on midscalp, more thin and non-growing hair.

Too much topical minoxidil can cause excessive hair growth, but stopping treatment reverses it.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.